Skip to content
ACA WEBINAR: MEN AND COVID SEVERITY – New Research that Links Them … What Are the Implications?
Earn 1.0 hour (0.1 CEUs) of continuing education credit when you purchase the webinar, MEN AND COVID SEVERITY – New Research that Links Them … What Are the Implications?
This activity explores recent research highlighting the hormonal differences that may contribute to why men experienced more severe outcomes from COVID-19 compared to women. Participants will examine the role of testosterone in immune response and how its levels—and conversion to other hormones like estradiol—may have influenced COVID-19 severity in male patients. The session will also address how this hormonal imbalance might relate to other acute viral illnesses beyond COVID-19, offering broader clinical insight.
In addition, the activity will cover current evidence on testosterone therapy and its impact on cardiovascular health and prostate cancer risk, including discussion of ongoing large-scale studies such as the TRAVERSE trial. Participants will review the physiological role of dihydrotestosterone (DHT), testosterone’s more potent metabolite, and how understanding these hormonal mechanisms can help guide discussions around men’s health.
By the end of the activity, pharmacists and pharmacy technicians will be better equipped to evaluate emerging literature, understand the implications of hormone-related research, and communicate effectively with both patients and healthcare providers. This knowledge will enhance their ability to engage in meaningful conversations about hormone therapy, risks and benefits, and personalized care approaches related to testosterone and viral disease outcomes.
Whether you’re interested in understanding the science behind COVID-19 severity in men or want to stay current on hormone-related health risks, this session offers timely, research-based insight for pharmacists and pharmacy technicians. Registration is below.
The American College of Apothecaries (ACA) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACA has accredited this knowledge-based program for 1 contact hour (0.1 CEUs) of continuing education credit for pharmacists and pharmacy technicians.
Register of Historic Places and is world-famous for its five resident Mallard ducks, who march daily through the lobby at 11am and 5pm.
Martha M. Rumore, PharmD, Esq, MS, LLM, FAPhA is a pharmacist-attorney in Frier Levitt’s Life Sciences Department. She is also a registered patent attorney and leads the firm’s Intellectual property team. She has broad and in-depth healthcare and regulatory experience. Her practice focuses on intellectual property (patents, trademarks, copyrights, trade secrets) and healthcare law, Food, Drug, Device & Cosmetic law (all facets-483s to clinical trials to registrations and product approval), pharmacy law and regulatory issues, 503A/503B compounding, Board of Pharmacy (licensing and disciplinary matters), PBM audits, and DSCSA supply chain compliance. Dr. Rumore has over 25 years of health-system, pharmaceutical industry, and law firm experience in the area of Food, Drug & Cosmetic Law, and pharmaceutical intellectual property Dr. Rumore is fluent in cGMPs, GCPs, writing and reviewing Clinical Trial Agreements (CTAs), Investigator brochures, manuscripts, labeling & advertising review, NDAs, study reports, and documents for regulatory submissions. She often prepares legal memoranda on healthcare/FDA matters and conducts Mock State Board of Pharmacy and FDA inspections for compounding pharmacies. Dr. Rumore has practiced both pharmacy and law. She has actual experience as a compounding pharmacist. She regularly counsels on Section 503A and state-specific compounding requirements, assesses compounding practices for state and federal regulatory compliance, including USP 797/795/800, medical necessity documentation, advertising & promotion, reimbursement issues, infrastructure, and preparing compounding policies and procedures that provide clear guidelines, standards, and training for staff. Previously, she was at the Director level in Drug Regulatory Affairs/Compliance in the pharmaceutical industry and hospital pharmacy. She taught Pharmacy Law, Drug Regulatory Affairs, and Food Drug & Cosmetic Law at several New York Colleges of Pharmacy and currently teaches Food, Drug & Cosmetic Law at Maurice A. Deane School of Law at Hofstra University. She is a frequent lecturer and has over 200 publications and presentations.
Dr. Jay Phipps, PharmD, MBA, FACA, FACVP, the pharmacy gladiator, is a pharmacy doctor, entrepreneur, president, and CEO at Phipps Pharmacy. Phipps Pharmacy is an independent pharmacy who provides pharmacy doctor provided patient care including traditional dispensing, compounding services, long-term care pharmacy services, and tailor-made prescription compounding to patients in middle and west Tennessee. Dr. Jay is also the President and CEO of PhippsCare that focuses on Pharmacy Doctor provided healthcare and Health Insurance Solutions which specializes in medical and pharmacy insurance plans for seniors.
